Delivery Order 36F79720D0180-36C24526N0724

<p>Veterans Integrated Service Network 5 issued a $34,873.77 delivery order to Novartis Pharmaceuticals Corporation on June 16, 2026, for FABHALTA 200 mg pharmaceutical supply, with an ultimate completion date of June 19, 2026.</p> <p>The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Cary, NC. Pricing is firm fixed price with no set-aside applied.</p>

<p>Veterans Integrated Service Network 5 issued a $34,873.77 delivery order to Novartis Pharmaceuticals Corporation on April 7, 2026, for FABHALTA 200 mg under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is priced firm fixed price with no set-aside and completes April 15, 2026. Place of performance is Cary, North Carolina.</p>

<p>Veterans Integrated Service Network 5 issued a delivery order to Novartis Pharmaceuticals Corporation on May 4, 2026, for Fabhalta 200 mg tablets for a patient at the Baltimore VA Medical Center, with a ceiling value of $34,873.77.</p> <p>The order is placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Cary, NC. The order is priced firm fixed-price with an ultimate completion date of May 11, 2026.</p>

The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a delivery order valued at $33.8K to Novartis Pharmaceuticals Corporation for the supply of FABHALTA 200 mg, a pharmaceutical product. The contract was awarded on October 21, 2025, with a completion date of October 24, 2025, and utilizes firm fixed-price pricing under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Performance of this delivery order will take place in Cary, North Carolina. No...

The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a $33.8K delivery order to Novartis Pharmaceuticals Corporation for FABHALTA 200 MG, a pharmaceutical product to be delivered to Cary, North Carolina. This firm fixed-price contract, awarded on December 16, 2025, with an ultimate completion date of December 19, 2025, was issued without a small business set-aside designation. The award falls under Novartis' existing Pharmaceuticals and Drugs Federal Supply Schedule...

Novartis Pharmaceuticals Corporation was awarded a delivery order valued at $34,873.77 by Veterans Integrated Service Network 5 (VISN 5) for FABHALTA 200 mg, a specialized pharmaceutical product supporting the Department of Veterans Affairs' healthcare mission. This firm fixed-price delivery order, with a completion date of February 23, 2026, was issued without a small business set-aside designation and reflects Novartis' role as a large pharmaceutical manufacturer competing directly in the...

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation, a large foreign-owned pharmaceutical manufacturer. The contract is for the drug Fabhalta 200 mg, with a ceiling value of $33,838.23 and an ultimate completion date of August 7, 2025. The contract was awarded on August 4, 2025 and does not have a set-aside designation. Novartis holds two significant federal contract vehicles with the VA - a $21.5 million Blanket...

This federal contract award is for the delivery of FABHALTA 200 MG, a pharmaceutical product, to the Department of Veterans Affairs (VA) through Novartis Pharmaceuticals Corporation's Federal Supply Schedule (FSS) contract. The contract has a ceiling value of $33,838.23 and a period of performance ending on March 21, 2025. The contract was awarded on March 14, 2025 and is a firm fixed-price delivery order, with no set-aside designation. Novartis, a foreign-owned, for-profit manufacturer of...

This is a federal contract award to Novartis Pharmaceuticals Corporation, a large foreign-owned pharmaceutical manufacturer, for the delivery of the drug Fabhalta 200 mg. The contract, valued at $33,838.23, is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has an ultimate completion date of August 28, 2025 and does not utilize a small business set-aside designation....

<p>The Medical Center for Federal Prisoners Springfield issued a $43,519.93 delivery order to Novartis Pharmaceuticals Corporation on July 1, 2026, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for FABHALTA 200 mg pharmaceutical supply. Place of performance is Cary, NC, with completion required by July 31, 2026. The order is priced on a firm fixed-price basis with no set-aside designation.</p>